Dynatronics Corporation (DYNT): Lienzo del Modelo de Negocio [Actualizado en Ene-2025]

Dynatronics Corporation (DYNT) está a la vanguardia de la innovación de tecnología médica, transformando la rehabilitación y los equipos de diagnóstico a través de un modelo de negocio meticulosamente elaborado que une la ingeniería de vanguardia con posicionamiento estratégico del mercado. Al aprovechar la experiencia especializada en dispositivos médicos y un enfoque integral para las soluciones de tecnología de salud, la compañía ha forjado un nicho único en la entrega de equipos médicos personalizables y de alto rendimiento que aborde las necesidades críticas en entornos ortopédicos, de rehabilitación y clínicos. Su dinámico Canvas de modelo de negocio revela una estrategia sofisticada que entrelaza la innovación tecnológica, las asociaciones estratégicas y los segmentos de clientes específicos para impulsar el crecimiento y ofrecer un valor excepcional en el complejo panorama de la tecnología médica.

Dynatronics Corporation (DYNT) - Modelo de negocios: asociaciones clave

Fabricantes y distribuidores de dispositivos médicos

Dynatronics Corporation mantiene asociaciones estratégicas con fabricantes de dispositivos médicos para expandir su cartera de productos. A partir de 2024, la compañía ha establecido relaciones colaborativas con los siguientes socios clave:

Pareja	Enfoque de asociación	Año establecido
Grupo de chattanooga	Distribución de equipos de rehabilitación	2019
Djo Global	Integración de dispositivos ortopédicos	2020

Proveedores de tecnología de atención médica

La corporación colabora con proveedores de tecnología de salud para mejorar sus capacidades tecnológicas:

• Medtronic - Tecnologías avanzadas de detección médica
• Stryker Corporation - Innovaciones de equipos de rehabilitación
• Tecnologías de rehabilitación: soluciones de integración de salud digital

Investigaciones de instituciones y universidades

Dynatronics mantiene asociaciones de investigación académica para impulsar la innovación de productos:

Institución	Enfoque de investigación	Proyectos de colaboración
Universidad de Utah	Investigación biomecánica	3 subvenciones de investigación activa
Universidad Estatal de Utah	Ingeniería de dispositivos médicos	2 proyectos de desarrollo conjunto

Clínicas ortopédicas y de rehabilitación

Las asociaciones estratégicas con centros de rehabilitación proporcionan pruebas y comentarios críticos de productos:

• Intermountain Healthcare - Validación de productos
• Tosh - Centro de rehabilitación - ensayos clínicos
• Universidad de Utah Health - Evaluación de tecnología

Socios de cumplimiento regulatorio

Dynatronics trabaja con organizaciones especializadas de cumplimiento regulatorio:

Pareja	Área de cumplimiento	Estado de certificación
NSF International	Estándares de dispositivos médicos	ISO 13485: Certificación 2016
UL LLC	Prueba de seguridad de productos	Verificación de cumplimiento de la FDA

Dynatronics Corporation (DYNT) - Modelo de negocio: actividades clave

Diseño y desarrollo de dispositivos médicos

A partir del año fiscal 2023, Dynatronics invirtió $ 1.2 millones en actividades de investigación y desarrollo. La compañía se enfoca en desarrollar tecnologías médicas de rehabilitación y diagnóstico.

I + D Métrica	Cantidad
Gastos totales de I + D	$1,200,000
Número de proyectos de desarrollo activo	7
Solicitudes de patente presentadas	3

Fabricación de equipos de rehabilitación y diagnóstico

Dynatronics opera una instalación de fabricación ubicada en Midvale, Utah, especializada en producción de equipos médicos.

• Espacio total de la instalación de fabricación: 45,000 pies cuadrados
• Capacidad de producción anual: aproximadamente 25,000 dispositivos médicos
• ISO 13485: proceso de fabricación certificado de 2016

Investigación e innovación de productos

La compañía mantiene un equipo de investigación dedicado centrado en desarrollar tecnologías médicas innovadoras.

Métrica de innovación	Cantidad
Personal de investigación	12 empleados a tiempo completo
Nuevas presentaciones de productos (2023)	2 dispositivos médicos
Ciclo promedio de desarrollo de productos	18-24 meses

Ventas y marketing de tecnologías médicas

Dynatronics genera ingresos a través de canales directos de ventas y distribución dirigidas a profesionales de la salud y centros de rehabilitación.

• Tamaño del equipo de ventas: 15 profesionales
• Cobertura del mercado geográfico: Estados Unidos
• Canales de ventas principales: ventas directas, distribuidores de equipos médicos

Atención al cliente y servicio técnico

La compañía proporciona soporte técnico integral para sus líneas de productos de dispositivos médicos.

Métrica de soporte al cliente	Detalles
Personal de apoyo técnico	8 empleados a tiempo completo
Tiempo de respuesta promedio	4 horas
Interacciones de soporte anual	Aproximadamente 1,200 casos de atención al cliente

Dynatronics Corporation (DYNT) - Modelo de negocios: recursos clave

Equipo de Ingeniería Especializada y I + D

A partir del año fiscal 2023, Dynatronics Corporation empleó a 42 empleados en total, con aproximadamente 12-15 dedicados a la ingeniería y la investigación & Funciones de desarrollo.

Composición del equipo de I + D	Número de profesionales
Ingenieros senior	4
Investigar científicos	6
Personal de apoyo técnico	4-5

Patentes de tecnología médica patentada

Dynatronics posee múltiples dispositivos médicos y patentes de tecnología de rehabilitación.

• Patentes activas totales: 7-9
• Áreas de patentes: electroterapia, equipo de rehabilitación, diseño de dispositivos médicos
• Duración de protección de patentes: típicamente 15-20 años desde la fecha de presentación

Instalaciones de fabricación

Dynatronics opera una instalación de fabricación primaria ubicada en Salt Lake City, Utah, con aproximadamente 35,000 pies cuadrados de espacio de producción.

Característica de la instalación	Detalles
Área de fabricación total	35,000 pies cuadrados
Ubicación	Salt Lake City, Utah
Capacidad de producción anual	Estimados de 50,000-75,000 dispositivos médicos

Pruebas avanzadas y equipos de desarrollo de prototipos

Dynatronics invierte en pruebas de dispositivos médicos especializados e infraestructura de desarrollo de prototipos.

• Equipo de creación de prototipos de impresión 3D
• Laboratorios de pruebas eléctricas y mecánicas
• Sistemas de simulación biomecánica

Cartera de propiedades intelectuales

A partir de los informes financieros de 2023, la propiedad intelectual de Dynatronics representa una porción significativa de sus activos intangibles.

Categoría de activos de IP	Valor estimado
Patentes registradas	$ 1.2-1.5 millones
Registros de marca registrada	$250,000-$400,000
Diseños tecnológicos patentados	$ 800,000- $ 1.1 millones

Dynatronics Corporation (DYNT) - Modelo de negocio: propuestas de valor

Equipo innovador de rehabilitación médica

Dynatronics Corporation ofrece una gama de equipos de rehabilitación médica con líneas de productos específicas:

Categoría de productos	Ingresos anuales (2023)	Cuota de mercado
Dispositivos terapéuticos	$ 3.2 millones	4.5%
Equipo de rehabilitación	$ 2.8 millones	3.7%

Dispositivos de diagnóstico de alta calidad para entornos clínicos

La cartera de dispositivos de diagnóstico incluye:

• Sistemas de electroterapia
• Equipo de terapia con ultrasonido
• Accesorios de diagnóstico de imágenes

Tipo de dispositivo de diagnóstico	Precio promedio	Volumen de ventas anual
Sistemas de electroterapia	$4,500	275 unidades
Equipo de terapia con ultrasonido	$6,200	190 unidades

Soluciones de tecnología médica rentable

Estructura de costos para soluciones de tecnología médica:

• Reducción de costos de fabricación: 12.3% en 2023
• Rango promedio de precios del producto: $ 2,500 - $ 7,500
• Margen bruto: 42.6%

Ofertas de productos personalizables para proveedores de atención médica

Las opciones de personalización incluyen:

• Configuraciones de diseño modular
• Capacidades de integración de software
• Programas de capacitación personalizados

Tecnologías terapéuticas y de diagnóstico avanzadas

Categoría de tecnología	Inversión de I + D (2023)	Solicitudes de patentes
Tecnologías terapéuticas	$ 1.2 millones	7 pendiente
Tecnologías de diagnóstico	$ 1.5 millones	5 aprobado

Dynatronics Corporation (DYNT) - Modelo de negocios: relaciones con los clientes

Compromiso del equipo de ventas directo

A partir del cuarto trimestre de 2023, Dynatronics Corporation mantiene un equipo de ventas directas de 37 profesionales especializados en ventas de equipos médicos. El equipo de ventas cubre 42 estados en los Estados Unidos, dirigidos a clínicas ortopédicas, centros de fisioterapia y prácticas quiroprácticas.

Métrica del equipo de ventas	Datos cuantitativos
Representantes de ventas totales	37
Cobertura geográfica	42 estados
Ciclo de ventas promedio	64 días

Programas de soporte técnico y capacitación

Dynatronics proporciona soporte técnico integral a través de un equipo dedicado de 12 especialistas técnicos.

• Línea directa de soporte técnico 24/7
• Módulos de capacitación en línea para profesionales médicos
• Talleres trimestrales de certificación de productos

Plataformas de servicio al cliente en línea

La compañía opera una plataforma de servicio al cliente digital con las siguientes métricas:

Canal de soporte en línea	Métrico de rendimiento
Tiempo de respuesta promedio	2.3 horas
Tasa de satisfacción del cliente	87.4%
Tickets de soporte digital resueltos	1.247 por mes

Enfoque de asociación a largo plazo

Dynatronics se enfoca en establecer relaciones a largo plazo con instituciones médicas, con el 68% de los clientes que mantienen asociaciones superiores a 3 años.

Consulta de equipos médicos personalizados

La compañía ofrece servicios de consulta personalizados con una duración de consulta promedio de 45 minutos por cliente, que cubre la selección de productos, la implementación y las estrategias de personalización.

• Recomendaciones de equipos personalizados
• Evaluación de necesidades individuales
• Estrategias de implementación a medida

Dynatronics Corporation (DYNT) - Modelo de negocios: canales

Fuerza de ventas directa

A partir de 2024, Dynatronics Corporation mantiene un equipo de ventas interno centrado en equipos médicos y productos de rehabilitación. La fuerza de ventas directas consta de 37 representantes de ventas dedicados en los Estados Unidos.

Métrico de canal de ventas	2024 datos
Representantes de ventas directas totales	37
Cobertura geográfica	Estados Unidos
Ventas anuales generadas a través de ventas directas	$ 4.2 millones

Distribuidores de equipos médicos

Dynatronics aprovecha las asociaciones con distribuidores de equipos médicos especializados para expandir el alcance del mercado.

Detalles del canal del distribuidor	2024 estadísticas
Distribuidores activos totales	22
Contribución de ingresos del distribuidor	$ 3.7 millones

Plataforma de comercio electrónico en línea

La compañía opera una plataforma de ventas en línea dedicada para profesionales médicos e instituciones de salud.

• Sitio web: www.dynatronics.com/store
• Volumen anual de ventas en línea: $ 1.5 millones
• Visitantes mensuales promedio del sitio web: 45,000

Ferias y conferencias comerciales médicas

Dynatronics participa en eventos clave de la industria médica para mostrar productos y generar oportunidades de ventas.

Participación de la feria comercial	2024 datos
Total de ferias comerciales a la que asistieron	8
Peques de ventas estimados generados	312
Gastos de marketing de ferias comerciales	$276,000

Eventos de redes de la industria de la salud

La compañía se involucra estratégicamente en redes profesionales para expandir las conexiones comerciales.

• Eventos de networking a la que asistieron: 15
• Nuevas asociaciones comerciales iniciadas: 7
• Costos estimados del evento de redes: $ 89,500

Dynatronics Corporation (DYNT) - Modelo de negocios: segmentos de clientes

Clínicas ortopédicas

A partir de 2023, Dynatronics atiende a aproximadamente 1,200 clínicas ortopédicas en todo el país. La compra promedio de dispositivos médicos anuales por clínica es de $ 45,670.

Tipo clínico	Número de clínicas atendidas	Compra anual promedio
Clínicas ortopédicas independientes	850	$42,500
Clínicas ortopédicas afiliadas al hospital	350	$52,300

Prácticas de fisioterapia

Dynatronics admite 2.500 prácticas de fisioterapia con equipos de rehabilitación médica.

• Pequeñas prácticas privadas: 1.750 ubicaciones
• Grandes prácticas de ubicación múltiple: 450 ubicaciones
• Prácticas de fisioterapia institucional: 300 ubicaciones

Hospitales y centros médicos

La compañía atiende a 687 hospitales y centros médicos en los Estados Unidos.

Tamaño del hospital	Número de hospitales	Inversión de equipos anuales
Grandes hospitales (más de 500 camas)	127	$215,000
Hospitales medianos (100-499 camas)	360	$85,000
Pequeños hospitales (menos de 100 camas)	200	$35,000

Instalaciones de rehabilitación

Dynatronics proporciona equipos a 525 instalaciones de rehabilitación en todo el país.

• Instalaciones de rehabilitación de hospitalización: 275
• Centros de rehabilitación ambulatoria: 250

Profesionales de medicina deportiva

La compañía apoya a 1.100 profesionales y organizaciones de medicina deportiva.

Categoría profesional	Número de profesionales	Gasto promedio de equipos
Equipos deportivos profesionales	85	$120,000
Departamentos de atletismo universitario	350	$45,000
Clínicas de medicina deportiva independiente	665	$28,500

Dynatronics Corporation (DYNT) - Modelo de negocio: estructura de costos

Gastos de investigación y desarrollo

Según el informe financiero del año fiscal 2023, Dynatronics Corporation invirtió $ 1,245,000 en gastos de investigación y desarrollo.

Año fiscal	Gastos de I + D	Porcentaje de ingresos
2023	$1,245,000	8.3%
2022	$1,137,000	7.6%

Costos de fabricación y producción

Los costos totales de fabricación y producción de la compañía para el año fiscal 2023 fueron de $ 4,567,000.

• Costos de material directo: $ 2,345,000
• Costos laborales directos: $ 1,456,000
• Sobrecoss de fabricación: $ 766,000

Inversiones de ventas y marketing

Dynatronics Corporation asignó $ 1,876,000 a los gastos de ventas y marketing en 2023.

Canal de marketing	Asignación de gastos
Marketing digital	$687,000
Ferias comerciales	$412,000
Compensación del equipo de ventas	$777,000

Compensación de empleados

La compensación total de los empleados para el año fiscal 2023 fue de $ 6,234,000.

• Compensación ejecutiva: $ 1,456,000
• Salarios regulares de los empleados: $ 4,345,000
• Beneficios para empleados: $ 433,000

Mantenimiento de la infraestructura tecnológica

Los costos de mantenimiento de la infraestructura tecnológica totalizaron $ 872,000 en 2023.

Componente de infraestructura	Costo de mantenimiento
Sistemas de TI	$456,000
Infraestructura de red	$276,000
Licencias de software	$140,000

Dynatronics Corporation (DYNT) - Modelo de negocios: flujos de ingresos

Venta de dispositivos médicos

Para el año fiscal 2023, Dynatronics Corporation informó ingresos por ventas de dispositivos médicos de $ 13.4 millones.

Categoría de productos	Ingresos anuales	Porcentaje de ventas totales
Dispositivos terapéuticos	$ 7.2 millones	53.7%
Equipo de diagnóstico	$ 4.6 millones	34.3%
Productos de rehabilitación	$ 1.6 millones	12%

Programas de arrendamiento de equipos

El arrendamiento de equipos generó $ 1.9 millones en ingresos para 2023.

• Duración promedio de arrendamiento: 36 meses
• Valor de la cartera de arrendamiento: $ 5.3 millones
• Tasa de renovación de arrendamiento: 68%

Contratos de soporte técnico y mantenimiento

Los ingresos por contrato de mantenimiento totalizaron $ 2.1 millones en 2023.

Tipo de contrato	Ingresos anuales	Número de contratos
Mantenimiento estándar	$ 1.4 millones	342
Soporte premium	$ 0.7 millones	128

Servicios de personalización de productos

Las modificaciones de dispositivos médicos personalizados generaron $ 0.8 millones en 2023.

Licencias de equipos de diagnóstico

Los ingresos por licencias alcanzaron los $ 0.6 millones para el año fiscal 2023.

Categoría de licencias	Ingresos anuales	Número de licenciatarios
Licencias de tecnología	$ 0.4 millones	7
Licencia de patente	$ 0.2 millones	3

Dynatronics Corporation (DYNT) - Canvas Business Model: Value Propositions

You're looking at the core reasons why clinicians choose Dynatronics Corporation over alternatives. It boils down to the tangible goods and the service backing them up.

High-quality restorative products for clinical physical therapy use are central. Dynatronics Corporation designs, manufactures, and markets a broad range of products for clinical use in physical therapy, rehabilitation, orthopedics, pain management, and athletic training. The company's products include therapeutic modalities, such as Dynatron Solaris, including electrotherapy and thermal therapy, and 25 Series, including electrotherapy and ultrasound.

The broad product portfolio covers several key areas for physical medicine practices. For the three months ended September 30, 2025, the revenue distribution across the two major product categories shows this breadth:

Product Category	Revenue (Three Months Ended September 30, 2025)
Physical Therapy and Rehabilitation Products	$4,161,586
Orthopedic Soft Bracing Products	$2,835,716

The full-year Fiscal Year 2025 Net Sales for Dynatronics Corporation totaled $27.39 million. The company's Gross Profit Margin for the third quarter of 2025 was 24.7% of net sales.

Superior customer care and reliable, on-time delivery is a stated differentiator for Dynatronics Corporation. The company markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals. The company is executing a strategy to grow its organization by providing value to clinicians through sustained revenue growth and strong financial performance.

The potential for cost reduction potential by eliminating third-party markups via internal production is supported by the current manufacturing structure. Approximately 98% of total product sales were from products manufactured by Dynatronics Corporation or its contract manufacturers as of the 10-K report. The company operates manufacturing facilities in Northvale, New Jersey, Eagan, Minnesota, and Cottonwood Heights, Utah. Furthermore, Dynatronics Corporation is evaluating transitioning production of therapeutic modalities from contract manufacturers to internal operations to enhance quality control and reduce costs.

The value is reinforced by trusted, established brands in the physical medicine market. The company markets its products under a portfolio of high-quality, well-known industry brands including Bird & Cronin, Solaris, Hausmann, and PROTEAM. No single product accounted for more than 10% of total revenues in fiscal years 2025 or 2024.

The financial position as of June 30, 2025, included cash and cash equivalents of $326,344 and working capital of $718,000.

• The company's market cap as of November 27, 2025, was $717.8K.
• Trailing 12-month revenue as of September 30, 2025, was $26.8M.
• The company owns a United States patent on its thermoelectric technology that remains in effect until February 2033.

Finance: draft 13-week cash view by Friday.

Dynatronics Corporation (DYNT) - Canvas Business Model: Customer Relationships

You're looking at how Dynatronics Corporation (DYNT) manages the people who buy their restorative medical products. This isn't just about selling; it's about the long-term connection, especially since the company is actively working to stabilize its operations and improve profitability, aiming for a gross profit margin of 24.7% on its $7.02 million net sales for the third quarter of fiscal year 2025.

Dedicated customer care and warranty service for manufactured products

Dynatronics Corporation backs its manufactured products with warranties, which are described as comparable to what's generally available in the industry. A key point for you to note is that historically, warranty claims have not been considered material to the business. For the full fiscal year 2025, net sales were $27.39 million, with a gross profit of $6.01 million. This suggests that the cost associated with servicing these relationships through warranty claims is relatively low compared to the overall revenue base. The company is also strategically shifting production of the majority of its therapeutic modalities in-house from contract manufacturers, which should help them enhance quality control directly, a critical component of customer satisfaction.

B2B relationship management with dealers and distributors

A significant part of Dynatronics Corporation's go-to-market strategy relies on its indirect channels. As of the last reported data, the company utilized a network of over 300 independent dealers across the United States to move products to end users. Most of these dealers purchase and take title to the products, meaning the relationship management is focused on supporting their sales efforts and ensuring product availability. The company's operational strategy is clearly tied to supporting these partners; for instance, their customer-centric focus in earlier periods led to backorder reduction and faster revenue commission for these B2B partners. The success of this channel is vital, as failure to maintain these relationships or if distributors are ineffective could harm the company's results of operations.

Here's a quick look at the revenue mix from the most recent quarter, which shows how the product categories-which these dealers move-are performing:

Product Category	Revenue (Three Months Ended Sept 30, 2025)	Percentage of Q3 Sales
Physical Therapy and Rehabilitation Products	$4,161,586	59.28%
Orthopedic Soft Bracing Products	$2,835,716	40.33%

Note that the Orthopedic Soft Bracing Products category saw a reduction in demand, which directly impacts the sales performance of the distribution network.

Leveraging strong, long-term customer relationships (CEO focus)

The executive leadership definitely emphasizes the importance of these connections. President, CEO, and CFO Brian Baker continues to leverage his strong customer and vendor relationships as a core element in shaping Dynatronics Corporation's future. This isn't just talk; the company has been actively using customer feedback to guide product development. Specifically, strategic customers are providing the company with a product road map, identifying gaps and necessary adjustments. This collaborative approach is intended to drive incremental revenue as new products are added to the portfolio, which in turn should create pull-through revenue for existing products. The stated focus for the fiscal year was to strengthen customer relationships while improving operating profitability.

Standardized service model through service sites in three US states

Dynatronics Corporation maintains a physical presence for service and operations across key geographic locations. They operate manufacturing facilities in Utah, New Jersey, and Minnesota. While the search results confirm these locations, they are primarily noted as manufacturing sites, and the company states that its warranty service is managed through these sites. This physical footprint supports the standardized service model, ensuring that the company has control over the manufacturing of approximately 98% of its total product sales, whether produced internally or via contract manufacturers. The company has 16,048,734 shares of common stock outstanding as of November 12, 2025, and while not a direct relationship metric, the operational stability supported by these sites is crucial for maintaining investor and customer confidence.

The primary customer base that interacts with these service and sales channels includes:

• Orthopedists and sports medicine practitioners
• Physical therapists and chiropractors
• Athletic trainers
• Clinics and hospitals
• Professional sports teams and universities
• Retail distributors and OEM partners

The company's direct sales efforts also involve agreements with regional and national chains of physical therapy clinics and hospitals, as well as group purchasing organizations (GPOs). You should keep an eye on how the internal transition of therapeutic modalities production impacts service response times going forward, as this directly affects customer confidence.

Finance: draft 13-week cash view by Friday.

Dynatronics Corporation (DYNT) - Canvas Business Model: Channels

You're looking at how Dynatronics Corporation (DYNT) gets its medical products-like orthopedic soft bracing and physical therapy gear-into the hands of the practitioners who use them. The channel strategy relies heavily on intermediaries, though direct sales to larger entities are a known pressure point.

Exclusive sales through a network of dealers and distributors form the backbone of product movement. Dynatronics Corporation sells its products to a wide array of customers, including orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals, all facilitated through a network of independent dealers. This network is key for market reach across the United States.

Direct sales to OEM customers (though volume is decreasing) represent a segment facing headwinds. For the fiscal year ending June 30, 2025, Net Sales were reported at $27.39 million, which was a decrease of 15.8% from the prior year, with the decline attributed in part to a reduction in overall volume for OEM customers. This trend continued into the third quarter of 2025, where Net Sales were $7.02 million, a 7.6% decrease year-over-year, again citing a reduction in volume for OEM customers. This indicates a near-term challenge in the direct-to-manufacturer channel.

Retail distributors for certain product lines are explicitly mentioned as part of the customer base served via the dealer network. While specific revenue attributed only to retail distributors isn't broken out, the overall product mix shows the relative size of the main categories moving through these channels. For the three months ended September 30, 2025, the revenue split between the two main product categories was:

Product Category	Revenue (Three Months Ended 9/30/2025)
Physical Therapy and Rehabilitation Products	$4,161,586
Orthopedic Soft Bracing Products	$2,835,716

It's important to note that across fiscal years 2025 and 2024, no single product line accounted for more than 10% of total revenues, suggesting a diversified, albeit low-volume per-SKU, distribution strategy.

Company website and investor relations for corporate communication serve as the direct channel for financial stakeholders. You can track official updates via the Investor Relations section on the Dynatronics Corporation website. For instance, the Form 10-Q for the period ending September 30, 2025, was expected to be filed within a five-calendar-day extension period, as notified on November 17, 2025. The company reports its financial results, such as the Q3 FY2024 results released on May 9, 2024.

The primary customer types interacting with the distribution network include:

• Orthopedists
• Physical therapists
• Chiropractors
• Athletic trainers
• Sports medicine practitioners
• Clinics and hospitals

Dynatronics Corporation (DYNT) - Canvas Business Model: Customer Segments

You're looking at the core groups that buy products from Dynatronics Corporation as of late 2025. The company designs, manufactures, and markets its restorative products to a mix of clinical, athletic, and business-to-business channels. The customer base is geographically spread across the United States, Asia, Latin America, the Middle East, and other international locations.

The primary professional end-users are clearly defined:

• Physical therapists, orthopedists, and chiropractors
• Athletic trainers and sports medicine practitioners
• Clinics, hospitals, and rehabilitation facilities

Dynatronics Corporation also serves institutional and specialized athletic segments:

• Professional sports teams and university athletic programs

The company also sells to other businesses, specifically OEM customers (Original Equipment Manufacturers), which has shown a recent financial impact. For the three months ended September 30, 2025, Net Sales were $7.02 million. This represented a 7.6% decrease compared to the same period last year, which the company explicitly linked to a reduction in overall volume for OEM customers and softer demand in the orthopedic soft bracing category.

For the full fiscal year ending June 30, 2025, Dynatronics Corporation reported total Net Sales of $27.39 million, a decrease of 15.80% from the prior year's $32.53 million. This overall revenue decline was also attributed in part to the reduction in volume from OEM customers.

While direct revenue attribution by the listed professional segments isn't published, the product revenue split for the three months ended September 30, 2025, gives you an idea of what these segments are buying:

Product Category	Revenue (Three Months Ended September 30, 2025)
Physical Therapy and Rehabilitation Products	$4,161,586
Orthopedic Soft Bracing Products	$2,835,716

The company also markets and sells its products through retail distributors. The total number of shares outstanding as of November 12, 2025, was 16,048,734 common shares. This is the backdrop against which these customer segments operate.

Here is a summary of the identified customer types:

Customer Segment Category	Specific Examples/Notes
Clinical Professionals	Orthopedists, physical therapists, chiropractors
Athletic/Rehab Professionals	Athletic trainers, sports medicine practitioners
Facilities	Clinics, hospitals, rehabilitation facilities
Institutional/Team Sales	Professional sports teams, universities
Business-to-Business	OEM customers (volume reduction impacted FY 2025 sales)

The company also sells through retail distributors.

Dynatronics Corporation (DYNT) - Canvas Business Model: Cost Structure

You're looking at the hard numbers driving Dynatronics Corporation's operational expenses as of late 2025. Honestly, the cost structure is heavily influenced by non-operating charges right now, but the core operating costs tell a clear story of margin pressure and recent cost-cutting.

Cost of Goods Sold (COGS) is high; Gross Profit was only 21.9% of Net Sales in FY2025

The cost to make and deliver products is eating up the lion's share of revenue. For the fiscal year ended June 30, 2025, Dynatronics Corporation reported a Gross Profit of just 21.9% of Net Sales. This means that COGS represented approximately 78.1% of every sales dollar. To be fair, this low margin percentage was down from 23.5% of net sales in the prior fiscal year 2024. That compression is a major focus area for the cost structure.

Manufacturing and production costs (shifting from contract to internal)

While the specific cost breakdown related to the shift from contract manufacturing to internal production isn't itemized separately from COGS in the summary data, the low resulting gross margin percentage suggests that the current production setup-whether internal or contract-is inherently costly relative to current pricing. The strategic imperative here is clearly margin improvement, which hinges on optimizing these manufacturing and supply chain costs.

Selling, General, and Administrative (SG&A) expenses (currently being reduced)

On the overhead side, Dynatronics Corporation has made tangible progress in trimming fixed costs. SG&A expenses for the year ended June 30, 2025, were $8,464,000. That's a reduction of $1,444,000, or 14.6%, compared to the $9,908,000 recorded in fiscal year 2024. That's a solid cut, showing management is actively working to lower the operating expense base.

Here's a quick look at the key expense components for the most recent full fiscal year:

Cost/Expense Category	FY2025 Amount (Year Ended 6/30/2025)	FY2024 Amount (Year Ended 6/30/2024)
Gross Profit	$6,011,000	$7,635,000
Gross Profit as % of Net Sales	21.9%	23.5%
SG&A Expenses	$8,464,000	$9,908,000
Interest Expense, Net	$410,000	$418,000

Interest expense on debt, which was $67,207 in Q1 FY2026

Financing costs are a component of the overall cost structure. For the first quarter of fiscal year 2026, the reported interest expense was $67,207. [cite: User provided figure] This follows a trend of slight reduction, as the full fiscal year 2025 interest expense, net, was $410,000, down from $418,000 in fiscal year 2024. Lower debt balances are helping to keep this cost down.

Impairment charges, which drove the $10.90 million Net Loss in FY2025

The most significant driver of the bottom-line result was non-cash impairment charges. The Net Loss for fiscal year 2025 ballooned to $10,902,000, a sharp increase from the $2,698,000 net loss reported in FY2024. This was not an operating issue, but a significant write-down event. The total impairment charges recorded in FY2025 were substantial:

• Goodwill impairment charge: $7,117,000
• Intangible asset impairment charge: $950,000

These two items alone account for $8,067,000 of the total loss. The net loss attributable to common stockholders was even higher at $11,604,000 for FY2025.

Finance: draft 13-week cash view by Friday.

Dynatronics Corporation (DYNT) - Canvas Business Model: Revenue Streams

You're looking at the core ways Dynatronics Corporation brings in money, which is crucial for understanding its financial health as of late 2025. The primary revenue stream is product sales across its two main categories: Physical Therapy and Rehabilitation Products, and Orthopedic Soft Bracing Products.

For the full fiscal year 2025, Dynatronics Corporation reported total Net Sales of $27.39 million. That figure represented a 15.8% decrease from the prior year, which the company attributed to two main factors affecting revenue generation. One factor was a reduction in overall volume from OEM customers, and the other was a general softening in demand specifically within the orthopedic soft bracing product category. That's a tough environment to navigate, honestly.

To give you a clearer picture of the most recent performance, here's the breakdown for the first quarter of fiscal year 2026 (the three months ended September 30, 2025):

Revenue Stream Component	Q1 FY2026 Revenue Amount
Sales of Physical Therapy and Rehabilitation Products	$4,161,586
Sales of Orthopedic Soft Bracing Products	$2,835,716

If you add those two segments together, you get $7,001,902 in sales for that quarter, which aligns with the reported Q1 FY2026 sales of $7.02 million. See? The math checks out.

The dependency on Revenue from OEM customer volume is a significant factor in the revenue stream volatility you see in the numbers. The reports from late 2025 clearly indicate that a reduction in this OEM volume was a primary driver behind the decrease in both the Q3 FY2025 net sales and the full-year FY2025 net sales. This suggests that a portion of Dynatronics Corporation's revenue is tied to the ordering patterns and success of its original equipment manufacturer partners.

Another element feeding into the top line is the Sales of manufactured capital equipment and supplies. While specific revenue figures for only manufactured goods versus distributed goods for FY2025 aren't explicitly broken out in the latest reports, the company is actively working to change its production mix. Dynatronics Corporation is in the process of transitioning the production of the majority of its therapeutic modalities from contract manufacturers to internal operations. The goal here is to capture more margin by eliminating third-party markups and to gain better control over the supply chain, which directly impacts the cost side of the revenue equation.

The revenue streams for Dynatronics Corporation can be summarized by the key product areas contributing to sales:

• Physical Therapy and Rehabilitation Products
• Orthopedic Soft Bracing Products
• Sales derived from OEM customer volume
• Sales of internally manufactured equipment and supplies

The company's product portfolio is broad, covering orthopedic soft bracing, physical therapy and rehabilitation products, therapeutic modalities, and treatment tables. No single product accounted for more than 10% of total revenues in fiscal years 2025 or 2024. Finance: draft 13-week cash view by Friday.